WO1991015512A3 - Polypeptides d'enveloppe du vih - Google Patents

Polypeptides d'enveloppe du vih Download PDF

Info

Publication number
WO1991015512A3
WO1991015512A3 PCT/US1991/002166 US9102166W WO9115512A3 WO 1991015512 A3 WO1991015512 A3 WO 1991015512A3 US 9102166 W US9102166 W US 9102166W WO 9115512 A3 WO9115512 A3 WO 9115512A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
hiv envelope
envelope polypeptides
antibodies
isolated
Prior art date
Application number
PCT/US1991/002166
Other languages
English (en)
Other versions
WO1991015512A2 (fr
Inventor
Timothy J Gregory
Cordelia K Leonard
Michael W Spellman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to JP91507619A priority Critical patent/JPH05506221A/ja
Publication of WO1991015512A2 publication Critical patent/WO1991015512A2/fr
Publication of WO1991015512A3 publication Critical patent/WO1991015512A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Nouveaux polypeptides isolés physiologiquement actifs et anticorps développés contre les polypeptides isolés. L'invention concerne également des procédés de préparation et d'emploi pharmaceutique des polypeptides ainsi que des anticorps.
PCT/US1991/002166 1990-04-03 1991-04-01 Polypeptides d'enveloppe du vih WO1991015512A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP91507619A JPH05506221A (ja) 1990-04-03 1991-04-01 Ｈｉｖエンベロープポリペプチド

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50477290A 1990-04-03 1990-04-03
US504,772 1990-04-03

Publications (2)

Publication Number Publication Date
WO1991015512A2 WO1991015512A2 (fr) 1991-10-17
WO1991015512A3 true WO1991015512A3 (fr) 1991-12-12

Family

ID=24007676

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/002166 WO1991015512A2 (fr) 1990-04-03 1991-04-01 Polypeptides d'enveloppe du vih

Country Status (5)

Country Link
EP (1) EP0527789A1 (fr)
JP (1) JPH05506221A (fr)
AU (1) AU7676891A (fr)
CA (1) CA2078545A1 (fr)
WO (1) WO1991015512A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133242T2 (de) * 1990-09-27 2004-02-19 Tripep Ab Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
CA2114849C (fr) * 1991-08-29 2007-04-24 Jay A. Berzofsky Antigenes peptidiques multideterminants qui stimulent la reponse des lymphocytes t auxiliaires contre le hiv chez une gamme de sujets humains
US5869624A (en) * 1993-03-26 1999-02-09 Progenics Pharmaceuticals, Inc. HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
AU700371B2 (en) 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
GB9615533D0 (en) * 1996-07-24 1996-09-04 Peptide Therapeutics Ltd Diagnostic test for herpes simplex virus type-2
US6271198B1 (en) 1996-11-06 2001-08-07 Genentech, Inc. Constrained helical peptides and methods of making same
DE69737415T2 (de) * 1996-11-06 2007-10-31 Genentech, Inc., South San Francisco Gespannte, helixformende peptide und verfahren um sie herzustellen
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 改変ｈｉｖｅｎｖポリペプチド
WO2003004620A2 (fr) 2001-07-05 2003-01-16 Chiron, Corporation Polynucleotides codant des polypeptides de type c du vih antigeniques, polypeptides et leurs utilisations
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US8715685B2 (en) * 2009-07-14 2014-05-06 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for HIV disease

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279688A2 (fr) * 1987-02-20 1988-08-24 Genentech, Inc. Méthodes et compositions pour l'utilisation de polypeptides env et anticorps anti-env de HIV
WO1989002277A2 (fr) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxie et therapie du syndrome immunodeficitaire acquis
WO1989003844A1 (fr) * 1987-10-28 1989-05-05 Ferring Ab Peptide de vih, antigenes artificiels de vih et kits d'immunodosage
WO1989005821A1 (fr) * 1987-12-21 1989-06-29 Arch Development Corporation Antigenes et anticorps associes au virus d'immunodeficience humaine
EP0326490A2 (fr) * 1988-01-27 1989-08-02 Biochem Immunosystems Inc. Peptides synthétiques et leur mélanges pour la détection d'anticorps HIV
EP0328403A2 (fr) * 1988-02-12 1989-08-16 United Biomedical Inc. Peptides synthétiques relatifs à la protéine HIV-GP120-env. et leur application

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279688A2 (fr) * 1987-02-20 1988-08-24 Genentech, Inc. Méthodes et compositions pour l'utilisation de polypeptides env et anticorps anti-env de HIV
WO1989002277A2 (fr) * 1987-08-28 1989-03-23 Board Of Regents, The University Of Texas System Prophylaxie et therapie du syndrome immunodeficitaire acquis
WO1989003844A1 (fr) * 1987-10-28 1989-05-05 Ferring Ab Peptide de vih, antigenes artificiels de vih et kits d'immunodosage
WO1989005821A1 (fr) * 1987-12-21 1989-06-29 Arch Development Corporation Antigenes et anticorps associes au virus d'immunodeficience humaine
EP0326490A2 (fr) * 1988-01-27 1989-08-02 Biochem Immunosystems Inc. Peptides synthétiques et leur mélanges pour la détection d'anticorps HIV
EP0328403A2 (fr) * 1988-02-12 1989-08-16 United Biomedical Inc. Peptides synthétiques relatifs à la protéine HIV-GP120-env. et leur application

Also Published As

Publication number Publication date
JPH05506221A (ja) 1993-09-16
AU7676891A (en) 1991-10-30
CA2078545A1 (fr) 1991-10-04
WO1991015512A2 (fr) 1991-10-17
EP0527789A1 (fr) 1993-02-24

Similar Documents

Publication Publication Date Title
CA2180816A1 (fr) 6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
EP0336760A3 (fr) Protéines induisant la croissance des os
AU2982889A (en) Novel dosage form of fenofibrate
EP0695171A1 (fr) Lyospheres contenant de la gonadotrophine
AU1750097A (en) Highly concentrated, lyophilized, and liquid factor ix formulations
IE830671L (en) 3-oxa-9-azatricyclo £3.3.1.0(2,4)| nonane derivatives.
WO1991015512A3 (fr) Polypeptides d'enveloppe du vih
CA2199679A1 (fr) Composes de dimethyl-(3-aryl-but-3-enyl)-amine comme ingredients actifs dans des produits pharmaceutiques
GR3031711T3 (en) Cephalosporins and homologues, preparations and pharmaceutical compositions.
AU7020787A (en) Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters
AU5612686A (en) Aids antigen, diagnosis and immunogenic compositions
AU7573087A (en) Substituted hydrazones, process for the preparation and their use as pesticide
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
AU8245087A (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
AU2614088A (en) Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
AU2624888A (en) Drug comprising the association of polymyxin b, netilmycin and amphotericin b, administered by spraying
AU8315287A (en) New alkanesulfonanilide and alkylaminosulfonanilide derivatives, processes for their preparation and pharmaceutical compositions comprising the same
EP0306219A3 (fr) Protéines et peptides du HIV pour le diagnostic, la prophylaxie et la thérapie du SIDA
AU2203688A (en) Novel polypeptides, the preparation thereof, the vectors for this, and drugs composed thereof
AU7143887A (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
AU8251591A (en) Novel pyrrolobenzimidazoles, imidazobenzoxazinones and imidazoquinolones, process for their preparation and their use and preparations containing the compounds
AU4442996A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
EP0385909A3 (fr) Kit ou composition pour la prévention ou le traitement des infections par HIV-1
EP0311228A3 (fr) Polypeptides recombinants et leur utilisation, y compris un diagnostic pour le virus du SIDA

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991908106

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2078545

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1991908106

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991908106

Country of ref document: EP